Acer Medical Inc. offers artificial intelligence, clinical data, and software for healthcare sector. The company offers VeriSee DR, an AI-assisted diagnostic software for diabetic retinopathy identification; VeriSee AMD, an AI-assisted screening software for age-related macular degeneration identification; VeriSee GLC, an AI-assisted screening software for glaucoma suspect; and VeriOsteo OP, an AI-assisted screening software for bone mineral density abnormalities. It also provides aiMed, a generative AI platform for healthcare environments; aiGait, balance and gait assessment software; non-mydriatic automated portable fundus camera; and portable X-ray system solutions. Acer Medical Inc. was founded in 2018 and is based in New Taipei City, Taiwan.
Frequently asked questions
What sector does Acer Medical Inc. (6857) operate in?
Acer Medical Inc. belongs to the Other sector and operates in the Health Information Services industry.
What is Acer Medical Inc. (6857) current stock price?
As of the latest data, Acer Medical Inc. stock price is NT$92.50, with a previous close of NT$92.50.
What is Acer Medical Inc. (6857) current market capitalization?
Acer Medical Inc. market cap is approximately 1.41 billion.
What is Acer Medical Inc. (6857) Earnings Per Share (EPS)?
The trailing EPS is -NT$1.95.
Does Acer Medical Inc. (6857) pay dividends?
No. Acer Medical Inc. does not pay a dividend.
What is Acer Medical Inc. (6857) beta (volatility) score?
Acer Medical Inc. has a beta of 0.699, indicating lower volatility than the overall market.
